POLYMORPHISMS IN THE HUMAN ALPHA4 INTEGRIN SUBUNIT GENE, SUITABLE FOR DIAGNOSIS AND TREATMENT OF INTEGRIN LIGAND MEDIATED DISEASES - Patent 1112381

(19)

(11)

EP 1 112 381 A1

(12)

(43)	Date of publication:
	04.07.2001 Bulletin 2001/27

(21)	Application number: 99946354.0

(22)	Date of filing: 15.09.1999

(51)	International Patent Classification (IPC)⁷: C12Q 1/68, G06F 17/30

(86)	International application number:
	PCT/GB9903/071

(87)	International publication number:
	WO 0017/394 (30.03.2000 Gazette 2000/13)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

19.09.1998 GB 9820339
10.11.1998 GB 9824506

(71)	Applicant: AstraZeneca AB
	151 85 Södertälje (SE)

(72)	Inventor:
	MORTEN, John Edward Norris Cheshire SK10 4TG (GB)

(74)	Representative: Giles, Allen Frank
	AstraZeneca,Global Intellectual Property Patents,PO Box 272,Mereside,Alderley Park Macclesfield,Cheshire SK10 4GR Macclesfield,Cheshire SK10 4GR (GB)

(54)	POLYMORPHISMS IN THE HUMAN ALPHA4 INTEGRIN SUBUNIT GENE, SUITABLE FOR DIAGNOSIS AND TREATMENT OF INTEGRIN LIGAND MEDIATED DISEASES